Streetbeat News

CMND

Clearmind Medicine Inc.

https://www.clearmindmedicine.com

Industry

Biotechnology

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

The article lists the stocks that have gained and lost the most in Thursday's mid-day session. Among the gainers, OpGen, Inc. (NASDAQ:OPGN) jumped 593% following two SEC filings, including a Preferred Stock Purchase Agreement. Secoo Holding Limited (NASDAQ:SECO) shares climbed 577.7% and Versus Systems Inc. (NASDAQ:VS) shares jumped 305%. Among the losers, RVL Pharmaceuticals plc (NASDAQ:RVLP) shares fell 52.4% as it agreed to effectuate a change of control transaction through prepackaged bankruptcy cases. Tempest Therapeutics, Inc. (NASDAQ:TPST) fell 50.2% and T2 Biosystems, Inc. (NASDAQ:TTOO) fell 39.8% after announcing a 1-for-100 reverse stock split.

Portfolio Pulse from Lisa Levin

October 12, 2023 | 4:55 pm

Shares of several companies including OpGen, Secoo Holding, ReShape Lifesciences, Jaguar Health, BSQUARE Corporation, Versus Systems, Lixiang Education Holding, Biocept, Taoping, and Jayud Global Logistics rose significantly in pre-market trading. On the other hand, stocks of Tempest Therapeutics, Agape ATP Corporation, Phio Pharmaceuticals, Wheeler Real Estate Investment Trust, Clearmind Medicine, Gaucho Group Holdings, AgileThought, Safe and Green Development Corporation, Freight Technologies, and Maris-Tech fell in pre-market trading.

Portfolio Pulse from Lisa Levin

October 12, 2023 | 1:29 pm

The article discusses recent developments in the field of psychedelic medicine, including new data from MAPS PBC's Phase 3 clinical study of MDMA-assisted therapy for PTSD, a study suggesting that combining MDMA with psilocybin or LSD could reduce difficult trips, and the House Rules Committee's vote on psychedelics amendments. It also mentions Scotland's approval of a pilot safer drug consumption site, and various milestones in the psychedelic drugs market. The article also provides an update on the performance of the AdvisorShares Psychedelics ETF (PSIL) and several psychedelic stocks.

Portfolio Pulse from Lara Goldstein

September 18, 2023 | 10:06 pm

UK-based venture studio Beckley Waves has raised $3.3 million in a funding round to expand safe and legal access to psychedelic therapies. The round was oversubscribed by 10% and included participation from several family and VC mission-aligned offices. The funds will be used for strategic investments into selected early-stage teams. In other news, Israeli biotech company Clearmind Medicine (NASDAQ:CMND) is pricing its US-only public offering, expecting to raise approximately $2.25 million. The offering consists of 7.5 million common shares and pre-funded warrants, and 7.5 million common warrants.

Portfolio Pulse from Lara Goldstein

September 15, 2023 | 4:09 pm

U.S. stocks traded higher with the Nasdaq Composite gaining more than 100 points. First Wave BioPharma shares spiked 23% after announcing a license agreement for capeserod from Sanofi. PFSweb shares shot up 48% after GXO Logistics announced it will acquire the company. MYT Netherlands Parent B.V. shares gained 13% after reporting Q4 financial results. IBEX Limited shares dropped 25% after reporting worse-than-expected Q4 results and issuing FY24 revenue guidance below estimates. Clearmind Medicine shares were down 57% after announcing pricing of a public offering. BIOLASE shares fell 38% after announcing pricing of a public offering.

Portfolio Pulse from Lisa Levin

September 14, 2023 | 6:30 pm

Several stocks experienced significant price movements in Wednesday's mid-day session. First Wave BioPharma shares jumped 89.5% after announcing a license agreement for capeserod from Sanofi. PFSweb gained 48.3% following GXO Logistics' acquisition announcement. Taseko Mines, Avalo Therapeutics, NeuBase Therapeutics, MYT Netherlands Parent, Soluna Holdings, Nikola Corporation, Trinseo, Alaunos Therapeutics, Orchestra BioMed Holdings, Eiger BioPharmaceuticals, Uniti Group, Lixiang Education Holding, TransCode Therapeutics, and Novo Integrated Sciences also saw gains. On the other hand, Sezzle, Clearmind Medicine, BIOLASE, OKYO Pharma, IBEX, Bionomics, MicroCloud Hologram, Harpoon Therapeutics, ZyVersa Therapeutics, Super League Enterprise, Axcella Health, BIMI International Medical, Impel Pharmaceuticals, PureCycle Technologies, Ivanhoe Electric, SIMPPLE, Iovance Biotherapeutics, Radiant Logistics, CS Disco, Ambipar Emergency Response, Genius Sports, and Vital Energy saw declines.

Portfolio Pulse from Lisa Levin

September 14, 2023 | 4:58 pm

U.S. stocks traded higher with the Nasdaq Composite gaining around 100 points. Energy shares jumped by 1.2%. First Wave BioPharma, PFSweb, and MYT Netherlands Parent shares rose significantly after positive news. However, IBEX Limited, Clearmind Medicine, and BIOLASE shares dropped due to negative financial results and public offerings. Oil traded up 1.7% to $90.04.

Portfolio Pulse from Lisa Levin

September 14, 2023 | 4:19 pm

Clearmind Medicine Inc (NASDAQ:CMND) announced the pricing of a $2.25 million public offering, causing its shares to drop by 53% to $0.18. The offering is expected to close on September 18. The company plans to use the proceeds for general corporate purposes, including R&D, working capital, future acquisitions, and capital expenditures.

Portfolio Pulse from Henry Khederian

September 14, 2023 | 3:03 pm

Clearmind announced the pricing of a $2.25 million public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 2:24 pm

US stocks traded higher following the release of PPI data, with the Dow, NASDAQ, and S&P 500 all seeing gains. Energy shares jumped by 1.4%, while consumer discretionary shares fell by 0.1%. US producer prices rose by 0.7% in August 2023, higher than the expected 0.4% increase. Shares of First Wave BioPharma, PFSweb, and TradeUP Acquisition Corp. saw significant increases, while shares of Sezzle, Clearmind Medicine, and BIOLASE fell sharply.

Portfolio Pulse from Lisa Levin

September 14, 2023 | 2:03 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.